Loading clinical trials...
Loading clinical trials...
To Establish a Prediction Model of Massive Blood Transfusion for Liver Transplantation Patients Based on Patient Blood Management
Based on the principle of patient blood management, this study aims to reduce the risk of blood transfusion in allogeneic liver transplantation patients, to ensure the safety of blood transfusion, and to provide new methods and basis for restrictive blood transfusion.
1. Preoperative variables and statistical analysis of a large number of intraoperative blood transfusions in allogeneic liver transplantation patients were performed to screen preoperative variables. 2. Models were established by machine learning algorithms to predict a large number of blood transfusions during surgery, providing a reference for preoperative blood preparation and postoperative outcome.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
the Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Start Date
March 20, 2019
Primary Completion Date
December 1, 2019
Completion Date
December 31, 2021
Last Updated
February 21, 2019
2,000
ESTIMATED participants
Liver transplant
PROCEDURE
Lead Sponsor
The Third Xiangya Hospital of Central South University
Collaborators
NCT06443515
NCT06244264
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions